Physician profile
Sana Ullah
NPI 1871786467
$3,561.66
in general payments reported to CMS, 2019-2025
35 companies · $864 in 2025
The $864 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $118 · 2021: $56.53 · 2022: $288 · 2023: $1,076 · 2024: $688 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,627.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $699.53 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $305.91 | 2019-2025 | Evenity, Tepezza, Prolia |
| Lilly USA, LLC | $265.85 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $242.92 | 2022-2024 | Freestyle Libre 3, Eterna |
| Mannkind Corporation | $188.40 | 2022-2025 | Afrezza |
| Dexcom, INC. | $183.60 | 2023-2024 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Abbvie INC. | $148.77 | 2022-2025 | Synthroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.64 | 2023-2025 | Jardiance |
| Medtronic, INC. | $125.83 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Radius Health, INC. | $120.14 | 2023-2025 | Tymlos |
| Xeris Pharmaceuticals, INC. | $97.70 | 2021-2024 | Gvoke Hypopen |
| Beta Bionics, INC. | $95.48 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Bayer Healthcare Pharmaceuticals INC. | $95.11 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $86.12 | 2023-2024 | |
| Tandem Diabetes Care, INC. | $83.67 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $68.48 | 2024-2025 | Korlym |
| Pfizer INC. | $57.73 | 2022-2025 | |
| Ibsa Pharma INC. | $54.56 | 2025 | Licart, Flector, Tirosint |
| Acella Pharmaceuticals, LLC | $53.91 | 2023-2024 | NP Thyroid 60 |
| Recordati_rare_diseases_inc. | $47.44 | 2023-2024 | Signifor Lar, Isturisa |
| Vivus LLC | $43.79 | 2023-2024 | Qsymia |
| Sequel Med Tech, LLC | $41.00 | 2025 | Twiist |
| Neurocrine Biosciences, INC. | $39.71 | 2025 | |
| Medtronic Minimed, INC. | $35.46 | 2019 | |
| Embecta Corp. | $29.93 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Cequr Corporation | $27.84 | 2022-2023 | Cequr Simplicity |
| Chiesi USA, INC. | $26.39 | 2025 | Mycapssa |
| Kyowa Kirin, INC. | $25.20 | 2024 | Crysvita |
| Companion Medical, INC. | $25.15 | 2019-2020 | |
| Ascendis Pharma Endocrinology INC | $24.89 | 2025 | Yorvipath |
| Ascensia Diabetes Care US INC. | $18.68 | 2025 | |
| Lifescan, INC. | $16.34 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.80 | 2023 | Cycloset |
| Esperion Therapeutics, INC. | $14.30 | 2023 | Nexletol |
| Janssen Pharmaceuticals, INC | $12.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sana Ullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.